 aggress primari gastrointestin lymphoma review patient regimen studi group d'etud de lymphom agressif purpos patient aggress primari gastrointestin lymphoma chemotherapi regimen efficaci intens combin chemotherapi role surgic debulk patient combin chemotherapi toxic modal patient method ninety-on patient primari gastrointestin lymphoma prospect multicent combin chemotherapi trial total number patient trial patient diffus larg cell diffus mix small cell lymphoma patient stage IE patient stage iie patient stage IV diseas patient stage IE stage iie stage IV diseas equal cm tumor specif site gastrointestin involv stomach small bowel ileocecum colon rectum surgic resect patient complet tumor excis patient cycl acvb text induct therapi sequenti consolid result treatment patient complet remiss partial remiss death median follow-up year patient relaps disease-fre surviv complet respond surviv entir group patient stage IE iie diseas complet respons surviv disease-fre surviv rate similar complet surgic resect incomplet surgic resect administr combin chemotherapi prognost factor surviv patient primari gastrointestin lymphoma similar patient regimen conclus patient aggress gastrointestin lymphoma intens chemotherapi outcom prognost factor compar patient similar-stag aggress lymphoma primari gastrointestin involv surgic resect administr combin chemotherapi complet respons rate surviv rate disease-fre surviv rate small group patient